Global Drug Delivery in Cancer Market Size, Status and Forecast 2024-2031

Report ID: 934850 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Liposomes
        1.2.3 PEGylated Proteins & Polypeptides
        1.2.4 Polymer Nanoparticle
        1.2.5 Protein–drug Conjugates
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Drug Delivery in Cancer Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals & Clinic
        1.3.3 Cancer Treatment Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Drug Delivery in Cancer Market Perspective (2016-2027)
    2.2 Drug Delivery in Cancer Growth Trends by Regions
        2.2.1 Drug Delivery in Cancer Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Drug Delivery in Cancer Historic Market Share by Regions (2016-2021)
        2.2.3 Drug Delivery in Cancer Forecasted Market Size by Regions (2022-2027)
    2.3 Drug Delivery in Cancer Industry Dynamic
        2.3.1 Drug Delivery in Cancer Market Trends
        2.3.2 Drug Delivery in Cancer Market Drivers
        2.3.3 Drug Delivery in Cancer Market Challenges
        2.3.4 Drug Delivery in Cancer Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Drug Delivery in Cancer Players by Revenue
        3.1.1 Global Top Drug Delivery in Cancer Players by Revenue (2016-2021)
        3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Players (2016-2021)
    3.2 Global Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Drug Delivery in Cancer Revenue
    3.4 Global Drug Delivery in Cancer Market Concentration Ratio
        3.4.1 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery in Cancer Revenue in 2020
    3.5 Drug Delivery in Cancer Key Players Head office and Area Served
    3.6 Key Players Drug Delivery in Cancer Product Solution and Service
    3.7 Date of Enter into Drug Delivery in Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Delivery in Cancer Breakdown Data by Type
    4.1 Global Drug Delivery in Cancer Historic Market Size by Type (2016-2021)
    4.2 Global Drug Delivery in Cancer Forecasted Market Size by Type (2022-2027)

5 Drug Delivery in Cancer Breakdown Data by Application
    5.1 Global Drug Delivery in Cancer Historic Market Size by Application (2016-2021)
    5.2 Global Drug Delivery in Cancer Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Drug Delivery in Cancer Market Size (2016-2027)
    6.2 North America Drug Delivery in Cancer Market Size by Type
        6.2.1 North America Drug Delivery in Cancer Market Size by Type (2016-2021)
        6.2.2 North America Drug Delivery in Cancer Market Size by Type (2022-2027)
        6.2.3 North America Drug Delivery in Cancer Market Size by Type (2016-2027)
    6.3 North America Drug Delivery in Cancer Market Size by Application
        6.3.1 North America Drug Delivery in Cancer Market Size by Application (2016-2021)
        6.3.2 North America Drug Delivery in Cancer Market Size by Application (2022-2027)
        6.3.3 North America Drug Delivery in Cancer Market Size by Application (2016-2027)
    6.4 North America Drug Delivery in Cancer Market Size by Country
        6.4.1 North America Drug Delivery in Cancer Market Size by Country (2016-2021)
        6.4.2 North America Drug Delivery in Cancer Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Drug Delivery in Cancer Market Size (2016-2027)
    7.2 Europe Drug Delivery in Cancer Market Size by Type
        7.2.1 Europe Drug Delivery in Cancer Market Size by Type (2016-2021)
        7.2.2 Europe Drug Delivery in Cancer Market Size by Type (2022-2027)
        7.2.3 Europe Drug Delivery in Cancer Market Size by Type (2016-2027)
    7.3 Europe Drug Delivery in Cancer Market Size by Application
        7.3.1 Europe Drug Delivery in Cancer Market Size by Application (2016-2021)
        7.3.2 Europe Drug Delivery in Cancer Market Size by Application (2022-2027)
        7.3.3 Europe Drug Delivery in Cancer Market Size by Application (2016-2027)
    7.4 Europe Drug Delivery in Cancer Market Size by Country
        7.4.1 Europe Drug Delivery in Cancer Market Size by Country (2016-2021)
        7.4.2 Europe Drug Delivery in Cancer Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Drug Delivery in Cancer Market Size (2016-2027)
    8.2 Asia-Pacific Drug Delivery in Cancer Market Size by Type
        8.2.1 Asia-Pacific Drug Delivery in Cancer Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Drug Delivery in Cancer Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Drug Delivery in Cancer Market Size by Type (2016-2027)
    8.3 Asia-Pacific Drug Delivery in Cancer Market Size by Application
        8.3.1 Asia-Pacific Drug Delivery in Cancer Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Drug Delivery in Cancer Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Drug Delivery in Cancer Market Size by Application (2016-2027)
    8.4 Asia-Pacific Drug Delivery in Cancer Market Size by Region
        8.4.1 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Drug Delivery in Cancer Market Size (2016-2027)
    9.2 Latin America Drug Delivery in Cancer Market Size by Type
        9.2.1 Latin America Drug Delivery in Cancer Market Size by Type (2016-2021)
        9.2.2 Latin America Drug Delivery in Cancer Market Size by Type (2022-2027)
        9.2.3 Latin America Drug Delivery in Cancer Market Size by Type (2016-2027)
    9.3 Latin America Drug Delivery in Cancer Market Size by Application
        9.3.1 Latin America Drug Delivery in Cancer Market Size by Application (2016-2021)
        9.3.2 Latin America Drug Delivery in Cancer Market Size by Application (2022-2027)
        9.3.3 Latin America Drug Delivery in Cancer Market Size by Application (2016-2027)
    9.4 Latin America Drug Delivery in Cancer Market Size by Country
        9.4.1 Latin America Drug Delivery in Cancer Market Size by Country (2016-2021)
        9.4.2 Latin America Drug Delivery in Cancer Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Drug Delivery in Cancer Market Size (2016-2027)
    10.2 Middle East & Africa Drug Delivery in Cancer Market Size by Type
        10.2.1 Middle East & Africa Drug Delivery in Cancer Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Drug Delivery in Cancer Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Drug Delivery in Cancer Market Size by Type (2016-2027)
    10.3 Middle East & Africa Drug Delivery in Cancer Market Size by Application
        10.3.1 Middle East & Africa Drug Delivery in Cancer Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Drug Delivery in Cancer Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Drug Delivery in Cancer Market Size by Application (2016-2027)
    10.4 Middle East & Africa Drug Delivery in Cancer Market Size by Country
        10.4.1 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Drug Delivery in Cancer Introduction
        11.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.1.5 Amgen Recent Development
    11.2 Teva
        11.2.1 Teva Company Details
        11.2.2 Teva Business Overview
        11.2.3 Teva Drug Delivery in Cancer Introduction
        11.2.4 Teva Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.2.5 Teva Recent Development
    11.3 UCB (Union Chimique Belge)
        11.3.1 UCB (Union Chimique Belge) Company Details
        11.3.2 UCB (Union Chimique Belge) Business Overview
        11.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Introduction
        11.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.3.5 UCB (Union Chimique Belge) Recent Development
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Drug Delivery in Cancer Introduction
        11.4.4 Roche Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.4.5 Roche Recent Development
    11.5 Celgene
        11.5.1 Celgene Company Details
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Drug Delivery in Cancer Introduction
        11.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.5.5 Celgene Recent Development
    11.6 Sanofi
        11.6.1 Sanofi Company Details
        11.6.2 Sanofi Business Overview
        11.6.3 Sanofi Drug Delivery in Cancer Introduction
        11.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.6.5 Sanofi Recent Development
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Drug Delivery in Cancer Introduction
        11.7.4 Merck Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.7.5 Merck Recent Development
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Company Details
        11.8.2 Johnson & Johnson Business Overview
        11.8.3 Johnson & Johnson Drug Delivery in Cancer Introduction
        11.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.8.5 Johnson & Johnson Recent Development
    11.9 Takeda
        11.9.1 Takeda Company Details
        11.9.2 Takeda Business Overview
        11.9.3 Takeda Drug Delivery in Cancer Introduction
        11.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.9.5 Takeda Recent Development
    11.10 Gilead Sciences
        11.10.1 Gilead Sciences Company Details
        11.10.2 Gilead Sciences Business Overview
        11.10.3 Gilead Sciences Drug Delivery in Cancer Introduction
        11.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.10.5 Gilead Sciences Recent Development
    11.11 Pfizer
        11.11.1 Pfizer Company Details
        11.11.2 Pfizer Business Overview
        11.11.3 Pfizer Drug Delivery in Cancer Introduction
        11.11.4 Pfizer Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.11.5 Pfizer Recent Development
    11.12 Dr Reddy
        11.12.1 Dr Reddy Company Details
        11.12.2 Dr Reddy Business Overview
        11.12.3 Dr Reddy Drug Delivery in Cancer Introduction
        11.12.4 Dr Reddy Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.12.5 Dr Reddy Recent Development
    11.13 Samyang Biopharmaceuticals
        11.13.1 Samyang Biopharmaceuticals Company Details
        11.13.2 Samyang Biopharmaceuticals Business Overview
        11.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Introduction
        11.13.4 Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.13.5 Samyang Biopharmaceuticals Recent Development
    11.14 Tolmar
        11.14.1 Tolmar Company Details
        11.14.2 Tolmar Business Overview
        11.14.3 Tolmar Drug Delivery in Cancer Introduction
        11.14.4 Tolmar Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.14.5 Tolmar Recent Development
    11.15 Astellas
        11.15.1 Astellas Company Details
        11.15.2 Astellas Business Overview
        11.15.3 Astellas Drug Delivery in Cancer Introduction
        11.15.4 Astellas Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.15.5 Astellas Recent Development
    11.16 AMAG Pharmaceuticals
        11.16.1 AMAG Pharmaceuticals Company Details
        11.16.2 AMAG Pharmaceuticals Business Overview
        11.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Introduction
        11.16.4 AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.16.5 AMAG Pharmaceuticals Recent Development
    11.17 AstraZeneca
        11.17.1 AstraZeneca Company Details
        11.17.2 AstraZeneca Business Overview
        11.17.3 AstraZeneca Drug Delivery in Cancer Introduction
        11.17.4 AstraZeneca Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.17.5 AstraZeneca Recent Development
    11.18 AbbVie
        11.18.1 AbbVie Company Details
        11.18.2 AbbVie Business Overview
        11.18.3 AbbVie Drug Delivery in Cancer Introduction
        11.18.4 AbbVie Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.18.5 AbbVie Recent Development
    11.18 Novartis
        .1 Novartis Company Details
        .2 Novartis Business Overview
        .3 Novartis Drug Delivery in Cancer Introduction
        .4 Novartis Revenue in Drug Delivery in Cancer Business (2016-2021)
        .5 Novartis Recent Development
    11.20 Aspen
        11.20.1 Aspen Company Details
        11.20.2 Aspen Business Overview
        11.20.3 Aspen Drug Delivery in Cancer Introduction
        11.20.4 Aspen Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.20.5 Aspen Recent Development
    11.21 Shire (Baxalta)
        11.21.1 Shire (Baxalta) Company Details
        11.21.2 Shire (Baxalta) Business Overview
        11.21.3 Shire (Baxalta) Drug Delivery in Cancer Introduction
        11.21.4 Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.21.5 Shire (Baxalta) Recent Development
    11.22 Breckenridge Pharmaceuticals
        11.22.1 Breckenridge Pharmaceuticals Company Details
        11.22.2 Breckenridge Pharmaceuticals Business Overview
        11.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Introduction
        11.22.4 Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.22.5 Breckenridge Pharmaceuticals Recent Development
    11.23 Galen Pharmaceuticals
        11.23.1 Galen Pharmaceuticals Company Details
        11.23.2 Galen Pharmaceuticals Business Overview
        11.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Introduction
        11.23.4 Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
        11.23.5 Galen Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Drug Delivery in Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Liposomes
    Table 3. Key Players of PEGylated Proteins & Polypeptides
    Table 4. Key Players of Polymer Nanoparticle
    Table 5. Key Players of Protein–drug Conjugates
    Table 6. Key Players of Others
    Table 7. Global Drug Delivery in Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Drug Delivery in Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Drug Delivery in Cancer Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Drug Delivery in Cancer Market Share by Regions (2016-2021)
    Table 11. Global Drug Delivery in Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Drug Delivery in Cancer Market Share by Regions (2022-2027)
    Table 13. Drug Delivery in Cancer Market Trends
    Table 14. Drug Delivery in Cancer Market Drivers
    Table 15. Drug Delivery in Cancer Market Challenges
    Table 16. Drug Delivery in Cancer Market Restraints
    Table 17. Global Drug Delivery in Cancer Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Drug Delivery in Cancer Market Share by Players (2016-2021)
    Table 19. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery in Cancer as of 2020)
    Table 20. Ranking of Global Top Drug Delivery in Cancer Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Drug Delivery in Cancer Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Drug Delivery in Cancer Product Solution and Service
    Table 24. Date of Enter into Drug Delivery in Cancer Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Drug Delivery in Cancer Revenue Market Share by Type (2016-2021)
    Table 28. Global Drug Delivery in Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Drug Delivery in Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Drug Delivery in Cancer Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Drug Delivery in Cancer Revenue Market Share by Application (2016-2021)
    Table 32. Global Drug Delivery in Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Drug Delivery in Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Amgen Company Details
    Table 65. Amgen Business Overview
    Table 66. Amgen Drug Delivery in Cancer Product
    Table 67. Amgen Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 68. Amgen Recent Development
    Table 69. Teva Company Details
    Table 70. Teva Business Overview
    Table 71. Teva Drug Delivery in Cancer Product
    Table 72. Teva Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 73. Teva Recent Development
    Table 74. UCB (Union Chimique Belge) Company Details
    Table 75. UCB (Union Chimique Belge) Business Overview
    Table 76. UCB (Union Chimique Belge) Drug Delivery in Cancer Product
    Table 77. UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 78. UCB (Union Chimique Belge) Recent Development
    Table 79. Roche Company Details
    Table 80. Roche Business Overview
    Table 81. Roche Drug Delivery in Cancer Product
    Table 82. Roche Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 83. Roche Recent Development
    Table 84. Celgene Company Details
    Table 85. Celgene Business Overview
    Table 86. Celgene Drug Delivery in Cancer Product
    Table 87. Celgene Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 88. Celgene Recent Development
    Table 89. Sanofi Company Details
    Table 90. Sanofi Business Overview
    Table 91. Sanofi Drug Delivery in Cancer Product
    Table 92. Sanofi Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 93. Sanofi Recent Development
    Table 94. Merck Company Details
    Table 95. Merck Business Overview
    Table 96. Merck Drug Delivery in Cancer Product
    Table 97. Merck Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 98. Merck Recent Development
    Table 99. Johnson & Johnson Company Details
    Table 100. Johnson & Johnson Business Overview
    Table 101. Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 102. Johnson & Johnson Recent Development
    Table 103. Takeda Company Details
    Table 104. Takeda Business Overview
    Table 105. Takeda Drug Delivery in Cancer Product
    Table 106. Takeda Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 107. Takeda Recent Development
    Table 108. Gilead Sciences Company Details
    Table 109. Gilead Sciences Business Overview
    Table 110. Gilead Sciences Drug Delivery in Cancer Product
    Table 111. Gilead Sciences Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 112. Gilead Sciences Recent Development
    Table 113. Pfizer Company Details
    Table 114. Pfizer Business Overview
    Table 115. Pfizer Drug Delivery in Cancer Product
    Table 116. Pfizer Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 117. Pfizer Recent Development
    Table 118. Dr Reddy Company Details
    Table 119. Dr Reddy Business Overview
    Table 120. Dr Reddy Drug Delivery in Cancer Product
    Table 121. Dr Reddy Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 122. Dr Reddy Recent Development
    Table 123. Samyang Biopharmaceuticals Company Details
    Table 124. Samyang Biopharmaceuticals Business Overview
    Table 125. Samyang Biopharmaceuticals Drug Delivery in Cancer Product
    Table 126. Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 127. Samyang Biopharmaceuticals Recent Development
    Table 128. Tolmar Company Details
    Table 129. Tolmar Business Overview
    Table 130. Tolmar Drug Delivery in Cancer Product
    Table 131. Tolmar Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 132. Tolmar Recent Development
    Table 133. Astellas Company Details
    Table 134. Astellas Business Overview
    Table 135. Astellas Drug Delivery in Cancer Product
    Table 136. Astellas Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 137. Astellas Recent Development
    Table 138. AMAG Pharmaceuticals Company Details
    Table 139. AMAG Pharmaceuticals Business Overview
    Table 140. AMAG Pharmaceuticals Drug Delivery in Cancer Product
    Table 141. AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 142. AMAG Pharmaceuticals Recent Development
    Table 143. AstraZeneca Company Details
    Table 144. AstraZeneca Business Overview
    Table 145. AstraZeneca Drug Delivery in Cancer Product
    Table 146. AstraZeneca Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 147. AstraZeneca Recent Development
    Table 148. AbbVie Company Details
    Table 149. AbbVie Business Overview
    Table 150. AbbVie Drug Delivery in Cancer Product
    Table 151. AbbVie Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 152. AbbVie Recent Development
    Table 153. Novartis Company Details
    Table 154. Novartis Business Overview
    Table 155. Novartis Drug Delivery in Cancer Product
    Table 156. Novartis Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 157. Novartis Recent Development
    Table 158. Aspen Company Details
    Table 159. Aspen Business Overview
    Table 160. Aspen Drug Delivery in Cancer Product
    Table 161. Aspen Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 162. Aspen Recent Development
    Table 163. Shire (Baxalta) Company Details
    Table 164. Shire (Baxalta) Business Overview
    Table 165. Shire (Baxalta) Drug Delivery in Cancer Product
    Table 166. Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 167. Shire (Baxalta) Recent Development
    Table 168. Breckenridge Pharmaceuticals Company Details
    Table 169. Breckenridge Pharmaceuticals Business Overview
    Table 170. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product
    Table 171. Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 172. Breckenridge Pharmaceuticals Recent Development
    Table 173. Galen Pharmaceuticals Company Details
    Table 174. Galen Pharmaceuticals Business Overview
    Table 175. Galen Pharmaceuticals Drug Delivery in Cancer Product
    Table 176. Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
    Table 177. Galen Pharmaceuticals Recent Development
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug Delivery in Cancer Market Share by Type: 2020 VS 2027
    Figure 2. Liposomes Features
    Figure 3. PEGylated Proteins & Polypeptides Features
    Figure 4. Polymer Nanoparticle Features
    Figure 5. Protein–drug Conjugates Features
    Figure 6. Others Features
    Figure 7. Global Drug Delivery in Cancer Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals & Clinic Case Studies
    Figure 9. Cancer Treatment Centers Case Studies
    Figure 10. Others Case Studies
    Figure 11. Drug Delivery in Cancer Report Years Considered
    Figure 12. Global Drug Delivery in Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Drug Delivery in Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Drug Delivery in Cancer Market Share by Regions: 2020 VS 2027
    Figure 15. Global Drug Delivery in Cancer Market Share by Regions (2022-2027)
    Figure 16. Global Drug Delivery in Cancer Market Share by Players in 2020
    Figure 17. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery in Cancer as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2020
    Figure 19. Global Drug Delivery in Cancer Revenue Market Share by Type (2016-2021)
    Figure 20. Global Drug Delivery in Cancer Revenue Market Share by Type (2022-2027)
    Figure 21. North America Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Drug Delivery in Cancer Market Share by Type (2016-2027)
    Figure 23. North America Drug Delivery in Cancer Market Share by Application (2016-2027)
    Figure 24. North America Drug Delivery in Cancer Market Share by Country (2016-2027)
    Figure 25. United States Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Drug Delivery in Cancer Market Share by Type (2016-2027)
    Figure 29. Europe Drug Delivery in Cancer Market Share by Application (2016-2027)
    Figure 30. Europe Drug Delivery in Cancer Market Share by Country (2016-2027)
    Figure 31. Germany Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Drug Delivery in Cancer Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Drug Delivery in Cancer Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Drug Delivery in Cancer Market Share by Region (2016-2027)
    Figure 41. China Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Drug Delivery in Cancer Market Share by Type (2016-2027)
    Figure 49. Latin America Drug Delivery in Cancer Market Share by Application (2016-2027)
    Figure 50. Latin America Drug Delivery in Cancer Market Share by Country (2016-2027)
    Figure 51. Mexico Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Drug Delivery in Cancer Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Drug Delivery in Cancer Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Drug Delivery in Cancer Market Share by Country (2016-2027)
    Figure 57. Turkey Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 61. Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 62. UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 63. Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 65. Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 66. Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 68. Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 69. Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 71. Dr Reddy Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 72. Samyang Biopharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 73. Tolmar Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 74. Astellas Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 75. AMAG Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 76. AstraZeneca Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 77. AbbVie Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 78. Novartis Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 79. Aspen Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 80. Shire (Baxalta) Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 81. Breckenridge Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 82. Galen Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Frequently Asked Questions
Drug Delivery in Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug Delivery in Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug Delivery in Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Long Acting Insulins

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for a ... Read More